Recent news reports have identified poorer outcomes in cancer patients from the UK compared with those in certain other European countries. Here, Mark Emberton, MD, FRCS, of University College London, London, UK, discusses the most commonly speculated reason for this: delayed diagnosis. Prof. Emberton postulates on the reasons for this delayed diagnosis and disucsses how the UK is addressing the issue. This video was recorded at the 2018 Genitourinary Cancers Symposium, held in San Francisco, CA.
Is delayed diagnosis in the UK to blame for poorer cancer outcomes?
